Table 6.

Analysis of assessment scores by adjuvant chemotherapy treatment in the Fast Recovery era

			Adjuvant chemotherapy
Assessment	Scale	Good score	Yes		No		AUROC (SE)
			N	Statistic	N	Statistic		p-value
Pre-operative assessments
Katz IADL (% scoring 6*)	0–6	High	26	26 (100%)	5	5 (100%)	0.50 (0.14)	1.000
Fried scale score	0–5	Low	27	1 (0–2)	7	1 (0–2)	0.52 (0.12)	0.896
Lawton ADL (% scoring 8*)	0–8	High	27	24 (89%)	7	6 (86%)	0.51 (0.12)	1.000
Clinical frailty scale	1–9	Low	27	2.3 ± 1.1	7	3.0 ± 0.8	0.71 (0.10)	0.087
Edmonton frail scale	0–18	Low	26	0 (0–2)	6	1 (1–2)	0.73 (0.09)	0.064
Mini nutritional assessment	0–14	High	27	10 (9–12)	7	11 (7–11)	0.59 (0.12)	0.507
MoCA score	0–30	High	19	26 (24–27)	6	25 (20–26)	0.68 (0.12)	0.201
Hand grip strength	Kg	High	20	31.3 ± 10.0	6	29.8 ± 11.1	0.55 (0.14)	0.733
Short physical performance (% scoring 12*)	0–12	High	22	17 (77%)	6	2 (33%)	0.72 (0.13)	0.043
Six-minute walk test	Metres	High	22	454 ± 112	6	277 ± 48	0.91 (0.06)	0.001
Post-operative assessments
Hand grip strength	Kg	High	25	28.2 ± 11.0	7	25.2 ± 8.2	0.60 (0.12)	0.453
Short physical performance	0–12	High	25	8 (6–12)	7	6 (5–7)	0.73 (0.11)	0.060
Six-minute walk test	Metres	High	23	243 ± 99	7	150 ± 124	0.79 (0.13)	0.019

Patients that died post-operatively were excluded from the analysis (N = 3). Data are reported as median (interquartile range) or as mean ± standard deviation, unless stated otherwise, with p-values from Mann–Whitney U tests. Bold p-values are significant at p < 0.05

^*The majority of the cohort scored the maximum number of points; hence, the proportion of cases with this score is reported to allow clearer comparison between groups; however, the p-values are based on the actual observed values

AUROC, area under the receiver operating characteristic curve; SE, standard error